The lecture duration is 25min.
0.5 CPD Points, 0.5 CME credits approval pending, 0.5 CEUs.
Accredited by CPDUK, Provider Pending and CBRN.
You can watch this lecture for free! For premium features, including a CPD/CME accredited certificate, to use time-coded note taking or get downloadable slides, you will need a fair price subscription.
537 million adults worldwide are living with diabetes mellitus (DM) and over 3 in 4 reside in low-and middle-income countries (LMICs). Patients, with or without DM, requiring critical care often experience dysglycemia—a combination of hyperglycemia due to illness/injury, hypoglycemia due to decreased oral intake/appetite, nausea/vomiting, as well as glucose variability which leads to increased risk of infection, hospital-acquired foot ulcers, length of stay, and overall mortality. Optimizing glycemic control when blood glucose rises above 180 mg/dL (10 mmol/L) via insulin infusion with a target range of 140-180 mg/dL (7.8-10 mmol/L) is a best practice for most critical care patients. Less than 1 in 10 people with diabetes in LMICs receive comprehensive glycemic control care. Improving the ability of health systems to provide treatment addressing glycemic control, as well as cardiovascular disease risk factors that so often accompany DM, e.g., hypertension and hypertriglyceridemia, are pressing international priorities.
Critical Care Nurses
Advanced Practice Providers
Critical Care Doctors
Upon completion of this activity, you should be able to:
None.